Effect of Extraneal (Icodextrin)on Triglyceride Levels in PD Patients
Effect of Extraneal (Icodextrin)on Triglyceride Levels in PD Patients
This is a Phase IV study evaluating triglyceride levels in peritoneal dialysis patients.
This prospective, open label, multi-center study evaluates the use of 7.5% icodextrin used in
 the long-dwell exchange in peritoneal dialysis patients with elevated triglyceride levels.
 Fasting triglyceride levels will be measured during the study.
Inclusion Criteria:

 -  written informed consent

 -  CAPD/APD on dialysis for at least 3 months

 -  Elevated fasting triglyceride levels

 Exclusion Criteria:

 -  enrolled in another study requiring IRB approval

 -  allergy to starch-based polymers

 -  glycogen storage disease

 -  maltose or isomaltose intolerance

 -  active alcohol/substance abuse

 -  Pregnant or nursing

 -  received an investigational drug within 30 days of screening